Pfizer Calls For Sustainable Approach To Ensure Viability Of Biosimilars Market
Changes Are Needed To Best Capitalize On Opportunities For Savings From Biosimilars
Global biosimilars player Pfizer is calling for a more sustainable approach to the market to ensure its long-term viability. In the second part of an exclusive interview, Barry Chester, the firm’s global commercial lead for supportive care oncology, tells Generics Bulletin where the company sees room for improvement.
